N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Phase 3 ClinicalTrials.gov

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

Sponsor: AstraZeneca • ClinicalTrials.gov ID: NCT07662109

Registry updated: 2026-08-31
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron and dapagliflozin in combination, compared with elecoglipron alone and dapagliflozin alone, in adults with type 2 diabetes mellitus (T2DM) inadequately managed with lifestyle management alone or treated with other background glucose-lowering medication.

Interventions

  • Elecoglipron (Drug)
    Elecoglipron is administered orally once daily.
  • Dapagliflozin (Drug)
    Dapagliflozin administered orally once daily.
  • Elecoglipron-matched placebo (Drug)
    A placebo matching elecoglipron administered orally once daily.
  • Dapagliflozin-matched placebo (Drug)
    A placebo matching dapagliflozin administered orally once daily.

Eligibility criteria

Inclusion Criteria: * Diagnosed with Type 2 Diabetes Mellitus (T2DM) for at least 90 days prior to screening * T2DM inadequately managed with lifestyle management alone or on stable treatment with other background glucose-lowering medication * HbA1c value of ≥ 7% to ≤ 10.5% (53 to 91.3 mmol/mol) * Body mass index (BMI) of ≥ 23 kg/m2 at screening * Stable body weight (self-reported or documented) for 90 days prior to screening Exclusion Criteria: * Type 1 Diabetes, secondary forms of diabetes (including congenital forms), or history of ketoacidosis or hyperosmolar coma * Currently receiving or anticipated to receive, therapeutic intervention for diabetic retinopathy and/or macular edema * Have had more than one episode of severe hypoglycemia within 180 days prior to screening or has a history of hypoglycemia unawareness or poor recognition of hypoglycemic symptoms * Clinically significant condition affecting the upper GI tract or chronic use of any medication that affects gastric motility or gastric emptying * History of acute or chronic pancreatitis * Severe congestive heart failure (New York Heart Association IV) * History/family history of medullary thyroid cancer or multiple endocrine neoplasia type 2

Conditions

Type 2 Diabetes Mellitus

Locations

  • Research Site — Huntsville, Alabama, United States
  • Research Site — Mobile, Alabama, United States
  • Research Site — Sheffield, Alabama, United States
  • Research Site — Little Rock, Arkansas, United States
  • Research Site — Bakersfield, California, United States
  • Research Site — Los Angeles, California, United States
  • Research Site — Ontario, California, United States
  • Research Site — Lake City, Florida, United States
  • Research Site — Lakeland, Florida, United States
  • Research Site — Atlanta, Georgia, United States
  • Research Site — Chicago, Illinois, United States
  • Research Site — Skokie, Illinois, United States
  • Research Site — Evansville, Indiana, United States
  • Research Site — Sioux City, Iowa, United States
  • Research Site — Zachary, Louisiana, United States
  • Research Site — Annapolis, Maryland, United States
  • Research Site — Lutherville-Timonium, Maryland, United States
  • Research Site — Oxon Hill, Maryland, United States
  • Research Site — Boston, Massachusetts, United States
  • Research Site — Boston, Massachusetts, United States
  • Research Site — Troy, Michigan, United States
  • Research Site — Ridgeland, Mississippi, United States
  • Research Site — Elkhorn, Nebraska, United States
  • Research Site — Albuquerque, New Mexico, United States
  • Research Site — Brooklyn, New York, United States
  • Research Site — Raleigh, North Carolina, United States
  • Research Site — Beachwood, Ohio, United States
  • Research Site — Maumee, Ohio, United States
  • Research Site — Norman, Oklahoma, United States
  • Research Site — Kingsport, Tennessee, United States
  • Research Site — Nashville, Tennessee, United States
  • Research Site — Dallas, Texas, United States
  • Research Site — McKinney, Texas, United States
  • Research Site — Paris, Texas, United States
  • Research Site — San Antonio, Texas, United States
  • Research Site — South Jordan, Utah, United States
  • Research Site — Arlington, Virginia, United States
  • Research Site — Newport News, Virginia, United States
  • Research Site — Redmond, Washington, United States
  • Research Site — Kingwood, West Virginia, United States
  • Research Site — Buenos Aires, Argentina
  • Research Site — Buenos Aires, Argentina
  • Research Site — CABA, Argentina
  • Research Site — Caba, Argentina
  • Research Site — Ciudad de Buenos Aires, Argentina
  • Research Site — Mar del Plata, Argentina
  • Research Site — Rosario, Argentina
  • Research Site — San Nicolás, Argentina
  • Research Site — San Vicente, Argentina
  • Research Site — Barretos, Brazil
  • Research Site — Brasília, Brazil
  • Research Site — Campinas, Brazil
  • Research Site — Curitiba, Brazil
  • Research Site — Fortaleza, Brazil
  • Research Site — Natal, Brazil
  • Research Site — Porto Alegre, Brazil
  • Research Site — Rio de Janeiro, Brazil
  • Research Site — São José dos Campos, Brazil
  • Research Site — São Paulo, Brazil
  • Research Site — São Paulo, Brazil
  • Research Site — Baotou, China
  • Research Site — Beijing, China
  • Research Site — Beijing, China
  • Research Site — Beijing, China
  • Research Site — Changde, China
  • Research Site — Changsha, China
  • Research Site — Changzhou, China
  • Research Site — Chengdu, China
  • Research Site — Chengdu, China
  • Research Site — Chenzhou, China
  • Research Site — Chifeng, China
  • Research Site — Hangzhou, China
  • Research Site — Hefei, China
  • Research Site — Huai'an, China
  • Research Site — Jinan, China
  • Research Site — Jincheng, China
  • Research Site — Jining, China
  • Research Site — Jinzhou Shi, China
  • Research Site — Kaifeng, China
  • Research Site — Langfang, China
  • Research Site — Liangyugang, China
  • Research Site — Luoyang, China
  • Research Site — Meihekou, China
  • Research Site — Nanjing, China
  • Research Site — Nantong, China
  • Research Site — Nanyang, China
  • Research Site — Pinggu, China
  • Research Site — Pingxiang, China
  • Research Site — Sanya, China
  • Research Site — Shanghai, China
  • Research Site — Shanghai, China
  • Research Site — Shantou, China
  • Research Site — Shenyang, China
  • Research Site — Shenyang, China
  • Research Site — Shijiazhuang, China
  • Research Site — Shijiazhuang, China
  • Research Site — Tianjin, China
  • Research Site — Wuhan, China
  • Research Site — Wuhu, China
  • Research Site — Xi'an, China
  • Research Site — Xiangyang, China
  • Research Site — Xianyang, China
  • Research Site — Xuzhou, China
  • Research Site — Xuzhou, China
  • Research Site — Yan’an, China
  • Research Site — Yueyang, China
  • Research Site — Zhumadian, China
  • Research Site — Zibo, China
  • Research Site — Hradec Králové, Czechia
  • Research Site — Humpolec, Czechia
  • Research Site — Jílové u Prahy, Czechia
  • Research Site — Ostrava, Czechia
  • Research Site — Prague, Czechia
  • Research Site — Prague, Czechia
  • Research Site — Prague, Czechia
  • Research Site — Příbram, Czechia
  • Research Site — Aarhus N, Denmark
  • Research Site — Esbjerg, Denmark
  • Research Site — Gandrup, Denmark
  • Research Site — Herlev, Denmark
  • Research Site — Hillerød, Denmark
  • Research Site — Hvidovre, Denmark
  • Research Site — Odense, Denmark
  • Research Site — Berlin, Germany
  • Research Site — Cologne, Germany
  • Research Site — Damme, Germany
  • Research Site — Deggingen, Germany
  • Research Site — Duisburg, Germany
  • Research Site — Essen, Germany
  • Research Site — Falkensee, Germany
  • Research Site — Frankfurt, Germany
  • Research Site — Hamburg, Germany
  • Research Site — Leipzig, Germany
  • Research Site — Münster, Germany
  • Research Site — Nittendorf, Germany
  • Research Site — Pohlheim, Germany
  • Research Site — Villingen-Schwenningen, Germany
  • Research Site — Wallerfing, Germany
  • Research Site — Weinheim, Germany
  • Research Site — Alexandroupoli, Greece
  • Research Site — Athens, Greece
  • Research Site — Athens, Greece
  • Research Site — Athens, Greece
  • Research Site — Ioannina, Greece
  • Research Site — Thessaloniki, Greece
  • Research Site — Thessaloniki, Greece
  • Research Site — Thessaloniki, Greece
  • Research Site — Budapest, Hungary
  • Research Site — Budapest, Hungary
  • Research Site — Debrecen, Hungary
  • Research Site — Salgótarján, Hungary
  • Research Site — Szeged, Hungary
  • Research Site — Szolnok, Hungary
  • Research Site — Zalaegerszeg, Hungary
  • Research Site — Bangalore, India
  • Research Site — Belagavi, India
  • Research Site — Belagavi, India
  • Research Site — Calicut, India
  • Research Site — Chennai, India
  • Research Site — Coimbatore, India
  • Research Site — Guwahati, India
  • Research Site — Indore, India
  • Research Site — Jaipur, India
  • Research Site — Kochi, India
  • Research Site — Kochi, India
  • Research Site — Lucknow, India
  • Research Site — Madurai, India
  • Research Site — Mumbai, India
  • Research Site — Nagpur, India
  • Research Site — New Delhi, India
  • Research Site — Thiruvananthapuram, India
  • Research Site — Chūōku, Japan
  • Research Site — Hachioji-shi, Japan
  • Research Site — Ichikawa-shi, Japan
  • Research Site — Kishiwada-shi, Japan
  • Research Site — Meguro-ku, Japan
  • Research Site — Mito, Japan
  • Research Site — Sapporo, Japan
  • Research Site — Shinjuku-ku, Japan
  • Research Site — Yamato-shi, Japan
  • Research Site — Alor Star, Malaysia
  • Research Site — Ipoh, Malaysia
  • Research Site — Kangar, Malaysia
  • Research Site — Kuala Lumpur, Malaysia
  • Research Site — Sarawak Miri, Malaysia
  • Research Site — Seremban, Malaysia
  • Research Site — Seri Manjung, Malaysia
  • Research Site — Cuernavaca, Mexico
  • Research Site — Bialystok, Poland
  • Research Site — Częstochowa, Poland
  • Research Site — Kielce, Poland
  • Research Site — Lodz, Poland
  • Research Site — Lublin, Poland
  • Research Site — Poznan, Poland
  • Research Site — Radom, Poland
  • Research Site — Warsaw, Poland
  • Research Site — Warsaw, Poland
  • Research Site — San Juan, Puerto Rico
  • Research Site — Brackenfell, South Africa
  • Research Site — Cape Town, South Africa
  • Research Site — Cape Town, South Africa
  • Research Site — Claremont, South Africa
  • Research Site — Durban, South Africa
  • Research Site — Durban, South Africa
  • Research Site — eMkhomazi, South Africa
  • Research Site — Johannesburg, South Africa
  • Research Site — KwaDukuza, South Africa
  • Research Site — Paarl, South Africa
  • Research Site — Pretoria, South Africa
  • Research Site — Goyang-si, South Korea
  • Research Site — Guri-si, South Korea
  • Research Site — Gwangju, South Korea
  • Research Site — Gyeonggi-do, South Korea
  • Research Site — Seoul, South Korea
  • Research Site — Seoul, South Korea
  • Research Site — Seoul, South Korea
  • Research Site — Yangsan, South Korea
  • Research Site — Changhua, Taiwan
  • Research Site — Kaohsiung City, Taiwan
  • Research Site — Kaohsiung City, Taiwan
  • Research Site — New Taipei City, Taiwan
  • Research Site — New Taipei City, Taiwan
  • Research Site — Taichung, Taiwan
  • Research Site — Taichung, Taiwan
  • Research Site — Taichung, Taiwan
  • Research Site — Tainan, Taiwan
  • Research Site — Tainan County, Taiwan
  • Research Site — Taipei, Taiwan
  • Research Site — Taoyuan, Taiwan
  • Research Site — Bangkok, Thailand
  • Research Site — Banphaeo, Thailand
  • Research Site — Changwat Sara Buri, Thailand
  • Research Site — Khlong Luang, Thailand
  • Research Site — Khon Kaen, Thailand
  • Research Site — Muang, Thailand
  • Research Site — Mueang, Thailand
  • Research Site — Ratchathewi, Thailand
  • Research Site — Ankara, Turkey (Türkiye)
  • Research Site — Ankara, Turkey (Türkiye)
  • Research Site — Gaziantep, Turkey (Türkiye)
  • Research Site — Istanbul, Turkey (Türkiye)
  • Research Site — Istanbul, Turkey (Türkiye)
  • Research Site — Istanbul, Turkey (Türkiye)
  • Research Site — Konya, Turkey (Türkiye)
  • Research Site — Kyiv, Ukraine
  • Research Site — Kyiv, Ukraine
  • Research Site — Kyiv, Ukraine
  • Research Site — Kyiv, Ukraine
  • Research Site — Kyiv, Ukraine
  • Research Site — Kyiv, Ukraine
  • Research Site — Lviv, Ukraine
  • Research Site — Lviv, Ukraine
  • Research Site — Uzhhorod, Ukraine
  • Research Site — Uzhhorod, Ukraine
  • Research Site — Vinnytsia, Ukraine
  • Research Site — Blackburn, United Kingdom
  • Research Site — Dundee, United Kingdom
  • Research Site — Guisborough, United Kingdom
  • Research Site — Nantwich, United Kingdom
  • Research Site — Rotherham, United Kingdom
  • Research Site — Thetford, United Kingdom
  • Research Site — Weston-super-Mare, United Kingdom
  • Research Site — Witney, United Kingdom
  • Research Site — Woodbridge, United Kingdom
  • Research Site — Yate, United Kingdom
  • Research Site — Hanoi, Vietnam
  • Research Site — Ho Chi Minh City, Vietnam
  • Research Site — Hochiminh City, Vietnam
  • Research Site — Hochiminh, Vietnam
  • Research Site — Hồ Chí Minh, Vietnam
  • Research Site — Huế, Vietnam
  • Research Site — Rach Gia, Vietnam
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record